contributors
Author: Adam Benjafield
Author
-
View all posts
Dr. Adam Benjafield is vice president of medical affairs at ResMed and convener of its academia-industry research collaboration medXcloud, as well as coauthor of the ALASKA study. He’s led more than 150 clinical studies ranging from product development and efficacy to international multicenter randomized controlled trials. He holds a bachelor’s and Ph.D. in medicine from the University of Sydney.
Recent Posts
-
November 9, 2021
Helping Obstructive Sleep Apnea Patients Live Longer
New research adds to mounting real-world evidence supporting the long-term clinical benefits of CPAPRead More →: Helping Obstructive Sleep Apnea Patients Live Longer